send to a friend by email

JPH posts net income of $7.64 million in 9M 2026

2026-11-12

According to the financial statements of Jerusalem Pharmaceuticals JPH for 30/09/2026, Net profit after tax reached 7,640,021 USD , compared with Net profit after tax of 7,402,153 USD of year 2025 a net increase of 3.21% and Total assets reached 121,158,514 USD , compared with Total assets of 114,587,652 USD at the end of year 2025 a net increase of 5.73% and Total Liabilities reached 25,893,105 USD , compared with Total Liabilities of 26,390,153 USD at the end of year 2025 a net decrease of 1.88% and Total Owners' Equity reached 95,265,409 USD Including Non-Controlling Interests of 1,120,892 USD, compared with Total Owners' Equity of 88,197,499 USD Including Non-Controlling Interests of 1,083,488 USD at the end of year 2025 a net increase of 8.01% Noting that paid-in capital increased from 18,000,000 USD in year 2025 to 36,000,000 USD of this year, a net increase of 100.00% .